AHEAD OF THE CURVE: Cystic Fibrosis

Portraits of Adherence: Patient-Centered Strategies in Cystic Fibrosis

Play Episode Listen Later Nov 30, 2015 106:12

Leading experts address the current evidence-based best practices, with educational and inspirational sessions on adherence, originally presented at the 29th North American Cystic Fibrosis Conference.

strategy patients portraits mutation cystic fibrosis adherence patient centered cystic fibrosis foundation phenotype genotype cftr

Ahead of the Curve: CFTR at 25 - Clinician and Patient Perspectives

Play Episode Listen Later Nov 7, 2014 96:02

Hear from Francis Collins, Tsui Lap-Chee, and Jack Riordan whose labs worked together to discover the CF gene. CF luminaries Bob Beall, Pamela Davis, Philip M. Farrell and others share how the discovery of the CF gene changed everything. Faculty present the clinical data and how patient care is evolving.

faculty genetics farrell clinicians cf cystic fibrosis francis collins ahead of the curve aotc patient perspectives philip m cftr pamela davis

Daniel: A Case for Early Intervention in Pseudomonas aeruginosa Eradication

Play Episode Listen Later Nov 6, 2014 81:57

Meet Daniel, a three-year-old whose routine throat culture just grew P. aeruginosa, originally presented at the 28th North American Cystic Fibrosis Conference.

cystic fibrosis early intervention eradication reinfection pseudomonas aeruginosa

Ahead of the Curve: The Diagnostic and Therapeutic Challenge

Play Episode Listen Later Nov 29, 2013 81:57

Originally presented at the 2013 North American Cystic Fibrosis Conference, this program covers differentiation of CF classes and current/potential therapies and using the CFTR2 database.

therapeutic mutation diagnostic cf cystic fibrosis ahead of the curve phenotype genotype pseudomonas cftr fev1 tobramycin ivacaftor

Ahead of the Curve: Inside CFTR 2013

Play Episode Listen Later Sep 1, 2013 55:56

Learn about the 5 classes of CFTR mutations, the latest research on emerging therapies for each mutation class and follow four individuals with CF. These case-based modules were presented at the 36th European Cystic Fibrosis Society Conference in Lisbon, Portugal.

portugal lisbon mutation cf cystic fibrosis pulmonary ahead of the curve phenotype genotype cftr fev1 f508del

Ahead of the Curve: Early Intervention in Cystic Fibrosis

Play Episode Listen Later Dec 21, 2012 109:08

This program examines state-of-the-art strategies for assessment of early lung disease in patients with CF. It reviews the importance of early intervention and optimal strategies to prevent airway obstruction in patients with CF

cf cystic fibrosis early intervention ahead of the curve pancreatic sweat test

July 2012: Volume 3, Number 12

Play Episode Listen Later Jul 23, 2012 41:11

eCystic Fibrosis Review: Featured Cases: Emerging Pathogens in Cystic Fibrosis

cystic fibrosis vancomycin fev1 amikacin

May 2013: Volume 4, Number 4

Play Episode Listen Later May 30, 2012 24:27

eCystic Fibrosis Review: Strategies for the Improvement of Nutrition Outcomes

health medicine nursing johns hopkins university cystic fibrosis cme respiratory therapist continuing medical education

November 2011 Volume 3, Issue 4

Play Episode Listen Later Nov 18, 2011 29:10

eCystic Fibrosis Review: Featured Cases: Exacerbation Therapies

antibiotics cystic fibrosis pneumothorax lung function staphylococcus aureus pseudomonas aeruginosa spirometry

March 2010: Volume 2, Number 4

Play Episode Listen Later Mar 9, 2010 33:47

eCystic Fibrosis Review:Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA)

cf fev1 aspergillosis omeprazole abpa itraconazole cyclodextrin voriconazole

Ahead of the Curve: Inside CFTR - a 3D Journey in to the Human Genome

Play Episode Listen Later Dec 31, 1969 79:33

This program describes the correlation between a patient’s CFTR genotype and their CF phenotype, explains the importance of genetic testing in suspected adult-onset CF, and identifies the practical uses of the CFTR2 database.

cf ahead of the curve pancreatic human genome cftr sweat test

Genetics Revolution: Program Goals and Understanding the Relationships of CF Phenotype

Play Episode Listen Later Dec 31, 1969 35:56

Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.

relationships goals medicine revolution md genetics cf johns hopkins university school mike boyle phenotype genotype emerging therapies fev1 disease modifying therapies homozygous potentiator f508del ivacaftor

Genetics Revolution: Emerging Therapies and Implementing Individualized Treatments

Play Episode Listen Later Dec 31, 1969 20:16

Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.

medicine revolution md treatments genetics implementing cf johns hopkins university school individualized mike boyle phenotype genotype emerging therapies fev1 disease modifying therapies homozygous potentiator f508del ivacaftor

Genetics Revolution: Seven Questions for the CF Care Team

Play Episode Listen Later Dec 31, 1969 34:53

Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.